DKK1 and breast carcinoma: In this study, we demonstrate that high levels of DKK1 in breast cancer create an immune suppressive microenvironment through direct inhibition of NK cell effector functions, and targeting DKK1 has significant anti-tumor effects in the primary and metastatic settings.